BTMDBiote Corp. Class A Common Stock

1.610USD+18.38%Mkt Cap: 54.58M $P/E: 11.50

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men …

Key Statistics

Company
Market Cap54.58M $
Enterprise Value167.51M $
Revenue (TTM)183.53M $
Gross Profit137.36M $
Net Income (TTM)27.05M $
Revenue/Share6.053 USD
Last Price1.610 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees223
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN
Valuation
P/E (Trailing)11.50
P/E (Forward)3.29
PEG
EV/EBITDA6.57
EV/Revenue0.91
P/S0.27
P/B-0.62
EPS (TTM)0.15
EPS (Forward)0.45
52W Range
1.27014% of range3.620
52W High3.620 USD
52W Low1.270 USD
Profitability
Gross Margin71.46%
Oper. Margin5.29%
EBITDA Margin13.88%
Profit Margin14.07%
ROE-46.20%
ROA25.13%
Growth
Revenue Growth-9.50%
Earnings Growth
Cash Flow & Leverage
Operating CF35.19M $
CapEx (TTM)6.86M $
FCF Margin-2.72%
FCF Yield-9.15%
Net Debt117.47M $
Net Debt/EBITDA4.61
Balance Sheet
Debt/Equity-1.88
Current Ratio1.43
Quick Ratio0.69
Book Value/Sh-2.3780 USD
Cash/Share0.3890 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.612 USD
Upside (mean)+62.2%
Target Range1.500 USD4.000 USD
$1.500+62.2% to mean$4.000
# Analysts5
Ownership
Shares Out.28.68M
Float17.84M
Insiders11.45%
Institutions63.06%
Short Interest
Short Ratio2.4d
Short % Float2.45%
Short % Out.1.78%
Shares Short538.65K
Short (prev mo.)553.64K
Technical
SMA 502.057 (-21.7%)
SMA 2002.159 (-25.4%)
Beta1.65
S&P 52W Chg18.16%
Avg Vol (30d)203.81K
Avg Vol (10d)390.25K
Technical Indicators
RSI (14)41.3
MACD-0.2102
MACD Signal-0.1676
MACD Hist.-0.0427
BB Upper2.656 USD
BB Middle1.867 USD
BB Lower1.078 USD
BB Width84.52%
ATR (14)0.1712 USD
Vol Ratio (20d)1.41x